vancomycin has been researched along with folic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Anderson, KE; Eliot, LA; Rogers, JA; Stevenson, BR | 1 |
| Bal, M; Chakraborty, SP; Mahapatra, SK; Pramanik, P; Roy, S; Sahu, SK; Santra, S | 1 |
| Chakraborty, SP; Pramanik, P; Roy, S; Sahu, SK | 2 |
| Cegłowski, M; Jasiecki, S; Schroeder, G | 1 |
| Chowdhuri, AR; Das, B; Kumar, A; Roy, S; Sahu, SK; Tripathy, S | 1 |
| Cui, Z; Liu, X; Mao, C; Wu, S; Xiang, Y; Yang, X; Yeung, KWK; Zheng, Y | 1 |
1 review(s) available for vancomycin and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for vancomycin and folic acid
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
Topics: Algorithms; Animals; Anti-Bacterial Agents; Area Under Curve; Caco-2 Cells; Calorimetry, Differential Scanning; Carrier Proteins; Chromatography, High Pressure Liquid; Drug Compounding; Drug Delivery Systems; Excipients; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Liposomes; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Spectrophotometry, Ultraviolet; Vancomycin | 2001 |
Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
Topics: Biocompatible Materials; Drug Carriers; Folic Acid; Molecular Structure; Nanoparticles; Nanotechnology; Polymers; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2010 |
In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus.
Topics: Adsorption; Anti-Bacterial Agents; Chitosan; Diethylamines; Drug Resistance, Bacterial; Folic Acid; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanoparticles; Potassium; Sodium-Potassium-Exchanging ATPase; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Vancomycin | 2012 |
Biocompatibility of folate-modified chitosan nanoparticles.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chitosan; Ethylamines; Folic Acid; HeLa Cells; Humans; Male; Materials Testing; Mice; Microbial Sensitivity Tests; Nanoparticles; Staphylococcus aureus; Vancomycin | 2012 |
Laser desorption/ionization mass spectrometric analysis of folic acid, vancomycin and Triton® X-100 on variously functionalized carbon nanotubes.
Topics: Folic Acid; Nanotubes, Carbon; Octoxynol; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2013 |
One-pot synthesis of multifunctional nanoscale metal-organic frameworks as an effective antibacterial agent against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Dynamic Light Scattering; Escherichia coli; Folic Acid; Intracellular Space; Luminescence; Metal-Organic Frameworks; Microbial Viability; Nanoparticles; Reactive Oxygen Species; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Vancomycin; X-Ray Diffraction | 2017 |
Infection-prevention on Ti implants by controlled drug release from folic acid/ZnO quantum dots sealed titania nanotubes.
Topics: Animals; Anti-Bacterial Agents; Cell Death; Cell Line; Delayed-Action Preparations; Drug Liberation; Folic Acid; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Microbial Viability; Nanotubes; Prosthesis-Related Infections; Quantum Dots; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Titanium; Vancomycin; Zinc Oxide | 2018 |